Home » Posts tagged with » off patent

The FDA’s War Against The Truth On Ivermectin

The FDA’s War Against The Truth On Ivermectin

by David R. Henderson and Charles L. Hooper On July 28, the Wall Street Journal ran our article “Why Is the FDA Attacking a Safe, Effective Drug?” In it, we outlined the potential value of the antiparasitic drug ivermectin for Covid-19, and we questioned the FDA’s vigorous attack on ivermectin. Many people praised us and many criticized […]